New studies have described the predictive signatures such as the expanded IFN-γ-induced immune signature (EIIS) and the T-cell-inflamed signature (TIS) within the GIST microenvironment showing the abundance of CD4+, CD8+ T cells, and M2 macrophages. The gene discussed is IFNG; the disease is gastrointestinal stromal tumor.